BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:ITC-6146RO readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of ITC-6146RO\, from ClinicalTrials.gov esti
 mates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07423117-2559@assetmemo.bio
DTSTAMP:20261121T005827Z
DTSTART;VALUE=DATE:20270630
DTEND;VALUE=DATE:20270701
SUMMARY:ITC-6146RO: Phase 1 readout est. (NCT07423117)
DESCRIPTION:ITC-6146RO\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: A St
 udy of ITC-6146RO in Patients With Advanced or Metastatic Cancer Who Have 
 Failed Standard Therapy\nEstimated primary completion: 30 June 2027. This 
 is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it c
 an move.\nDrug page: https://assetmemo.bio/drug/itc-6146ro#upcoming-events
 \nRegistry record: https://clinicaltrials.gov/study/NCT07423117
URL:https://assetmemo.bio/drug/itc-6146ro#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
